We are live on ! Find out more
OCUL icon

Ocular Therapeutix
OCUL

72 hedge funds and large institutions have $128M invested in Ocular Therapeutix in 2016 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 30 increasing their positions, 12 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

150% more repeat investments, than reductions

Existing positions increased: 30 | Existing positions reduced: 12

33% more capital invested

Capital invested by funds: $96.4M → $128M (+$32.1M)

17% more call options, than puts

Call options by funds: $1.29M | Put options by funds: $1.11M

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

4% less funds holding

Funds holding: 75 → 72 (-3)

23% less first-time investments, than exits

New positions opened: 10 | Existing positions closed: 13

Holders
72
Holders Change
-3
Holders Change %
-4%
% of All Funds
1.92%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.08%
New
10
Increased
30
Reduced
12
Closed
13
Calls
$1.29M
Puts
$1.11M
Net Calls
+$187K
Net Calls Change
+$20K

Top Buyers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
+$2.89M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$1.65M
3
CCI
Columbus Circle Investors
+$1.29M
4
BIT
BlackRock Institutional Trust
California
+$861K
5
BCM
Bridgeway Capital Management
Texas
+$610K

Top Sellers

Rank Fund Capital Flow
1
Federated Hermes
Federated Hermes
Pennsylvania
-$6.92M
2
PGCM
Prescott Group Capital Management
Oklahoma
-$1.75M
3
OM
Opaleye Management
Massachusetts
-$1.29M
4
Fidelity Investments
Fidelity Investments
Massachusetts
-$1.2M
5
Acadian Asset Management
Acadian Asset Management
Massachusetts
-$422K
Name Holding Trade Value Shares
Change 		Change in
Stake
EDRS
26
Edmond de Rothschild (Suisse)
Switzerland
$481K – – –
CI
27
Cowen Inc
New York
$470K -$357K -58,504 -46%
PC
28
Polar Capital
United Kingdom
$395K -$106K -17,373 -23%
RPAM
29
Rhenman & Partners Asset Management
Sweden
$275K – – –
Wells Fargo
30
Wells Fargo
California
$266K +$4.58K +752 +2%
SM
31
Sabby Management
Florida
$262K +$232K +38,100 New
California State Teachers Retirement System (CalSTRS)
32
California State Teachers Retirement System (CalSTRS)
California
$261K +$2.44K +400 +1%
AA
33
ALPS Advisors
Colorado
$217K -$19.2K -3,149 -9%
CS
34
Credit Suisse
Switzerland
$189K +$61.9K +10,163 +58%
AllianceBernstein
35
AllianceBernstein
Tennessee
$188K – – –
TA
36
Teachers Advisors
New York
$174K – – –
SSA
37
Schonfeld Strategic Advisors
New York
$143K +$7.52K +1,233 +6%
CG
38
Cutler Group
California
$143K +$118K +19,403 +1,294%
Swiss National Bank
39
Swiss National Bank
Switzerland
$131K – – –
Charles Schwab
40
Charles Schwab
California
$128K – – –
ProShare Advisors
41
ProShare Advisors
Maryland
$120K -$19.5K -3,200 -16%
EMG
42
Ellington Management Group
Connecticut
$116K +$36K +5,900 +54%
D.E. Shaw & Co
43
D.E. Shaw & Co
New York
$104K -$254K -41,740 -73%
VKH
44
Virtu KCG Holdings
New York
$92K +$81.8K +13,414 New
RhumbLine Advisers
45
RhumbLine Advisers
Massachusetts
$91K +$1.4K +230 +2%
BG
46
BlackRock Group
United Kingdom
$90K – – –
New York State Common Retirement Fund
47
New York State Common Retirement Fund
New York
$88K – – –
CA
48
Corrado Advisors
New Jersey
$84K +$74.8K +12,275 New
NFA
49
Nationwide Fund Advisors
Ohio
$77K – – –
AIG
50
American International Group
New York
$70.9K +$91 +15 +0.1%
1
2
3 4

OCUL Hedge Fund Activity: Q3 2016 in Review

72 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Ocular Therapeutix (OCUL) for Q3 2016, worth a combined $128M — up 33% from $96.4M a quarter earlier.

Sellers outnumbered buyers: 13 funds closed out of OCUL and 10 opened new positions — a net loss of 3 holders — while 12 trimmed existing stakes and 30 added.

The largest buyer was Morgan Stanley, adding an estimated $2.89M. The largest seller was Federated Hermes, cutting an estimated $6.92M.

  • 72 institutional investors held Ocular Therapeutix (OCUL) as of Q3 2016, down from 75 in Q2 2016.
  • Funds reported $128M of Ocular Therapeutix stock for Q3 2016, up 33% quarter-over-quarter.
  • 10 funds opened new Ocular Therapeutix positions in Q3 2016 and 13 closed out, a net change of -3 holders.
  • The largest Ocular Therapeutix buyer in Q3 2016 was Morgan Stanley, an estimated $2.89M added.
  • The largest Ocular Therapeutix seller in Q3 2016 was Federated Hermes, an estimated $6.92M sold.

Based on aggregated 13F filings for Q3 2016.